155 related articles for article (PubMed ID: 21575103)
1. Protein kinase C β inhibition ameliorates experimental mesangial proliferative glomerulonephritis.
Tokuyama H; Kim S; Zhang Y; Langham RG; Cox AJ; Gow RM; Kelly DJ; Gilbert RE
Nephrology (Carlton); 2011 Sep; 16(7):649-55. PubMed ID: 21575103
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase C-beta inhibition attenuates the progression of nephropathy in non-diabetic kidney disease.
Kelly DJ; Edgley AJ; Zhang Y; Thai K; Tan SM; Cox AJ; Advani A; Connelly KA; Whiteside CI; Gilbert RE
Nephrol Dial Transplant; 2009 Jun; 24(6):1782-90. PubMed ID: 19155535
[TBL] [Abstract][Full Text] [Related]
3. PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis.
Gilbert RE; Kelly DJ; McKay T; Chadban S; Hill PA; Cooper ME; Atkins RC; Nikolic-Paterson DJ
Kidney Int; 2001 Apr; 59(4):1324-32. PubMed ID: 11260393
[TBL] [Abstract][Full Text] [Related]
4. S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis.
Martini S; Krämer S; Loof T; Wang-Rosenke Y; Daig U; Budde K; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1761-70. PubMed ID: 17356129
[TBL] [Abstract][Full Text] [Related]
5. Tranilast ameliorates experimental mesangial proliferative glomerulonephritis.
Tokuyama H; Kelly DJ; Cox A; Zhang Y; Thai K; Nikolic-Paterson DJ; Gilbert RE
Nephron Exp Nephrol; 2008; 109(1):e1-7. PubMed ID: 18480612
[TBL] [Abstract][Full Text] [Related]
6. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
[TBL] [Abstract][Full Text] [Related]
7. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
[TBL] [Abstract][Full Text] [Related]
8. Experimental mesangial proliferative glomerulonephritis (the anti-Thy-1.1 model).
Jefferson JA; Johnson RJ
J Nephrol; 1999; 12(5):297-307. PubMed ID: 10630692
[TBL] [Abstract][Full Text] [Related]
9. Multi-glycoside of Tripterygium wilfordii Hook f. ameliorates proteinuria and acute mesangial injury induced by anti-Thy1.1 monoclonal antibody.
Wan Y; Gu L; Suzuki K; Karasawa T; Fujioka Y; Han GD; Koike H; Kawachi H; Shimizu F
Nephron Exp Nephrol; 2005; 99(4):e121-9. PubMed ID: 15722645
[TBL] [Abstract][Full Text] [Related]
10. [FTY720 attenuates rat anti-Thy-1 mesangial proliferative glomerulonephritis by inhibition of transforming growth factor β1-connective tissue growth factor pathway].
Jiang JY; Huang XD; Wang Y; Deng AP; Zhou JH
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):107-11. PubMed ID: 22455887
[TBL] [Abstract][Full Text] [Related]
11. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
[TBL] [Abstract][Full Text] [Related]
12. Effects of histone deacetylase inhibitors on rat mesangial cells.
Freidkin I; Herman M; Tobar A; Chagnac A; Ori Y; Korzets A; Gafter U
Am J Physiol Renal Physiol; 2010 Feb; 298(2):F426-34. PubMed ID: 19923417
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect of sulphated hyaluronic acid, a potential selectin-blocking agent, on experimental progressive mesangial proliferative glomerulonephritis.
Matsuda M; Shikata K; Shimizu F; Suzuki Y; Miyasaka M; Kawachi H; Kawashima H; Wada J; Sugimoto H; Shikata Y; Ogawa D; Tojo SJ; Akima K; Makino H
J Pathol; 2002 Nov; 198(3):407-14. PubMed ID: 12375274
[TBL] [Abstract][Full Text] [Related]
14. Multi-glycoside of Tripterygium wilfordii Hook. f. reduces proteinuria through improving podocyte slit diaphragm dysfunction in anti-Thy1.1 glomerulonephritis.
Wan YG; Sun W; Zhen YJ; Che XY; Pu HP; Wang Y; Li M; Ruan JG; Yan QJ
J Ethnopharmacol; 2011 Jun; 136(2):322-33. PubMed ID: 21570456
[TBL] [Abstract][Full Text] [Related]
15. Low-dose mTOR inhibition by rapamycin attenuates progression in anti-thy1-induced chronic glomerulosclerosis of the rat.
Krämer S; Wang-Rosenke Y; Scholl V; Binder E; Loof T; Khadzhynov D; Kawachi H; Shimizu F; Diekmann F; Budde K; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2008 Feb; 294(2):F440-9. PubMed ID: 18094032
[TBL] [Abstract][Full Text] [Related]
16. Goto-Kakizaki rat is protected from proteinuria after induction of anti-Thy1 nephritis.
Riley SG; Evans RA; Davies M; Floege J; Phillips AO
Am J Kidney Dis; 2002 May; 39(5):985-1000. PubMed ID: 11979342
[TBL] [Abstract][Full Text] [Related]
17. PKC-beta1 mediates glucose-induced Akt activation and TGF-beta1 upregulation in mesangial cells.
Wu D; Peng F; Zhang B; Ingram AJ; Kelly DJ; Gilbert RE; Gao B; Krepinsky JC
J Am Soc Nephrol; 2009 Mar; 20(3):554-66. PubMed ID: 19211711
[TBL] [Abstract][Full Text] [Related]
18. Thrombospondin peptides are potent inhibitors of mesangial and glomerular endothelial cell proliferation in vitro and in vivo.
Hugo CP; Pichler RP; Schulze-Lohoff E; Pröls F; Adler S; Krutsch HC; Murphy-Ullrich JE; Couser WG; Roberts DD; Johnson RJ
Kidney Int; 1999 Jun; 55(6):2236-49. PubMed ID: 10354272
[TBL] [Abstract][Full Text] [Related]
19. Decreased collagen-degrading activity could be a marker of prolonged mesangial matrix expansion.
Tomita M; Koike H; Han GD; Shimizu F; Kawachi H
Clin Exp Nephrol; 2004 Mar; 8(1):17-26. PubMed ID: 15067512
[TBL] [Abstract][Full Text] [Related]
20. ERK5 activation enhances mesangial cell viability and collagen matrix accumulation in rat progressive glomerulonephritis.
Urushihara M; Takamatsu M; Shimizu M; Kondo S; Kinoshita Y; Suga K; Kitamura A; Matsuura S; Yoshizumi M; Tamaki T; Kawachi H; Kagami S
Am J Physiol Renal Physiol; 2010 Jan; 298(1):F167-76. PubMed ID: 19846573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]